Our results are only conclusive for CeD and show that approximately 1 out of 22 CF patients were positive for TGA-IgA, 1 out of 40 were positive for TGA-IgA plus EMA-IgA, and 1 out of 55 had biopsy-verified CeD, numbers that are considerably higher than those measured in the general population. Here, CD79A is linked to cranioectodermal dysplasia.